| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |